Kresnier Perez

Randomised Control Trials (RCTs) are considered the gold standard in clinical research for evaluating the efficacy of new treatments or interventions. By randomly assigning participants to either a treatment group or a control group, RCTs aim to eliminate bias and ensure that the results are attributable to the intervention itself rather than other confounding variables. […]

Phase I trials represent a critical first step in the clinical research process, primarily focusing on assessing the safety and tolerability of new drugs or treatments. These trials are typically the first time a new intervention is tested in humans, following extensive preclinical studies that may include laboratory and animal testing. The primary objective of

Phase I clinical trials represent a critical juncture in the drug development process, serving as the first step in evaluating a new pharmaceutical compound’s safety and pharmacokinetics in human subjects. These trials are primarily designed to assess how a drug behaves in the body, including its absorption, distribution, metabolism, and excretion. Typically, Phase I trials

Clinical research management is a critical component of the healthcare landscape, serving as the backbone for the development of new therapies, drugs, and medical devices. The significance of effective clinical research management cannot be overstated, as it directly influences the quality, efficiency, and integrity of clinical trials. By overseeing the planning, execution, and analysis of

The NanoPatch is an innovative investigational device that represents a significant advancement in the field of vaccination technology. Developed by researchers at the University of Queensland, this device aims to revolutionize how vaccines are administered, making the process more efficient, less painful, and potentially more effective. The NanoPatch is a small, adhesive patch embedded with

Good Clinical Practice (GCP) is an international quality standard that is essential for conducting clinical trials involving human subjects. It encompasses a set of guidelines and principles that ensure the integrity of data collected during clinical research and the protection of the rights, safety, and well-being of participants. GCP is not merely a regulatory requirement;

Clinical trials are a cornerstone of modern medicine, serving as the primary method for evaluating the safety and efficacy of new treatments, drugs, and medical devices. These meticulously designed studies are essential for advancing healthcare, as they provide the evidence needed to support regulatory approvals and clinical practice guidelines. The process typically involves several phases,

Clinical Trial Units (CTUs) serve as pivotal entities within the landscape of medical research, acting as specialized facilities designed to conduct clinical trials efficiently and effectively. These units are often affiliated with academic institutions, hospitals, or research organizations, and they play a crucial role in the development of new therapies, drugs, and medical devices. By

Clinical Research Management Systems (CRMS) have emerged as pivotal tools in the landscape of clinical trials and research. These systems are designed to streamline the complex processes involved in managing clinical studies, from initial planning through to execution and reporting. As the demand for efficient and effective clinical research grows, particularly in the wake of

Interactive Response Technology (IRT) refers to a suite of tools and systems designed to facilitate real-time interaction between presenters and their audiences. This technology encompasses various methods, including clickers, mobile applications, and web-based platforms that allow participants to respond to questions, polls, or quizzes during a presentation or event. The primary goal of IRT is